Jumpei Taguchi, Yosuke Yamada, Sho Ohta, Fumie Nakasuka, Takuya Yamamoto, Manabu Ozawa, Yasuhiro Yamada. A versatile in vivo platform for reversible control of transgene expression in adult tissues. Stem cell reports. 2024
Sho Ohta, Yasuhiro Yamada. Exploring the potential of in vivo reprogramming for studying embryonic development, tissue regeneration, and organismal aging. Current Opinion in Genetics & Development. 2023. 81. 102067-102067
Yui Shimada-Takayama, Takayuki Yasuda, Tomoyo Ukai, Jumpei Taguchi, Manabu Ozawa, Nao Sankoda, Sho Ohta, Yasuhiro Yamada. Generation of mice for evaluating endogenous p16Ink4a protein expression. Biochemical and biophysical research communications. 2022. 599. 43-50
Kenji Ito, Kohei Nagata, Sho Ohta, Yutaka Matsuda, Tomoyo Ukai, Ichiro Yasuda, Akira Ota, Ryota Kobayashi, Mio Kabata, Nao Sankoda, et al. The oncogene-dependent resistance to reprogramming unveils cancer therapeutic targets. Cell Reports. 2022. 39. 4. 110721-110721